The online assessment does not constitute a medical consultation until reviewed by a licensed provider
GHK-Cu 50MG is supplied by NuRev Peptides strictly for laboratory research and testing purposes, in line with our age verification and research-use policy
A Note on Safety and Sequencing: While potent, these peptides are not "magic bullets." We utilize a Phased Protocol : Phase 1 focuses on extinguishing inflammation (BPC-157, Selank, NAD+), while Phase 2 focuses on aggressive growth (Dihexa, Semax)
Sustained elevation of IGF-1 reduces hypothalamic GHRH output and increases somatostatin tone, limiting the pituitary response
Each lot undergoes analytical verification and quality-control review
The NHS Digital Weight Management Programme typically requires a BMI 30 kg/m (or 27.5 kg/m for certain ethnic groups) plus additional risk factors such as diabetes or hypertension